Skip to main content
SpringerLink
Log in

Pathogenic relevance of autoantibodies in dilated cardiomyopathy

  • Chapter
Inflammatory Cardiomyopathy (DCMi)

Part of the book series: Progress in Inflammation Research ((PIR))

  • 728 Accesses

Abstract

Dilated cardiomyopathy (DCM) is a heart muscle disease of unknown origin characterized by progressive cardiac dilatation and loss of contractile function in the absence of coronary artery disease. Genetic causes and cardiotoxic substances account for about one third of the cases, but the etiology of the two other thirds is still poorly understood. However, within the past two decades evidence has grown continuously that autoimmunity to certain cardiac antigens may play an important role in the development of DCM. Recent experiments in rodents even indicate that autoantibodies targeting the cardiac β1 (catecholamine) receptor can actually cause the disease. Dependent on the individual genetic predisposition, such harmful autoimmune reactions most likely occur as a result of heart muscle damage induced by viral triggers, ischemia, and/or exposure to cardiotoxins leading to myocyte apoptosis or necrosis, and subsequent liberation of self antigens previously hidden to the immune system. The following article reviews current evidence and recent experimental and clinical findings focusing on the possible role of autoantibodies against a confined number of cardiac self antigens in the pathogenesis of DCM.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen I, Thiene G, Goodwin J, Gyarfas I et al (1996) Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Circulation 93: 841–842

    CAS  PubMed  Google Scholar 

  2. American Heart Association (2007) Dallas; Heart disease and stroke statistics-2007 update. Circulation 115: e69–e171

    Article  Google Scholar 

  3. Morita H, Seidman J, Seidman CE (2005) Genetic causes of human heart failure. J Clin Invest 115: 518–526

    CAS  PubMed  Google Scholar 

  4. Fabrizio L, Regan TJ (1994) Alcoholic cardiomyopathy. Cardiovasc Drugs Ther 8: 89–94

    Article  CAS  PubMed  Google Scholar 

  5. Chien KR (2000) Myocyte survival pathways and cardiomyopathy: Implications for trastuzumab cardiotoxicity. Semin Oncol 27: 9–17

    CAS  PubMed  Google Scholar 

  6. Freedman NJ, Lefkowitz RJ (2004) Anti-beta1-adrenergic receptor antibodies and heart failure: Causation, not just correlation. J Clin Invest 113: 1379–1382

    CAS  PubMed  Google Scholar 

  7. Jahns R, Boivin V, Lohse MJ (2006) Beta1-adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy. Trends Cardiovasc Med 16: 20–24

    Article  CAS  PubMed  Google Scholar 

  8. Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP (2005) Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112: 1965–1970

    Article  PubMed  Google Scholar 

  9. Limas CJ (1997) Cardiac autoantibodies in dilated cardiomyopathy. Circulation 95: 1979–1980

    CAS  PubMed  Google Scholar 

  10. Luppi P, Rudert WA, Zanone MM, Stassi G, Trucco G, Finegold D, Boyle GJ, Del Nido P, McGowan FX, Trucco M (1998) Idiopathic dilated cardiomyopathy. A superantigendriven autoimmune disease. Circulation 98: 777–785

    CAS  PubMed  Google Scholar 

  11. Mahrholdt H, Wagner A, Deluggi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock C-T et al (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114: 1581–1590

    Article  PubMed  Google Scholar 

  12. MacLellan WR, Lusis AJ (2003) Dilated cardiomyopathy: Learning to live with yourself. Nat Med 9: 1455–1456

    Article  CAS  PubMed  Google Scholar 

  13. Smulski C, Labovsky V, Levy G, Hontebeyrie M, Hoebeke J, Levin MJ (2006) Structural basis of the cross-reaction between an antibody to the Trypanosoma cruzi ribosomal P2beta protein and the human beta1-adrenergic receptor. FASEB J 20: 1396–1406

    Article  CAS  PubMed  Google Scholar 

  14. Maekawa Y, Ouzounian M, Opavsky MA, Liu PP (2007) Connecting the missing link between dilated cardiomyopathy and viral myocarditis. Circulation 115: 5–8

    Article  PubMed  Google Scholar 

  15. Schultheiss HP, Bolte HD (1985) Immunological analysis of autoantibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol 17: 603–617

    Article  CAS  PubMed  Google Scholar 

  16. Schultheiss HP, Kühl U, Janda I, Melzner B, Ulrich G, Morad M (1988) Antibodymediated enhancement of calcium permeability in cardiac myocytes. J Exp Med 168: 2102–2109

    Article  Google Scholar 

  17. Schulze K, Witzenbichler B, Christmann C, Schultheiss HP (1999) Disturbance of myocardial energy metabolism in experimental virus myocarditis by antibodies against the adenine nucleotide translocator. Cardiovasc Res 44: 91–100

    Article  CAS  PubMed  Google Scholar 

  18. Pohlner K, Portig I, Pankuweit S, Lottspeich F, Maisch B (1997) Identification of mitochondrial antigens recognized by the antibody in sera of patients with dilated cardiomyopathy by two-dimensional gel electrophoresis and protein sequencing. Am J Cardiol 80: 1040–1045

    Article  CAS  PubMed  Google Scholar 

  19. Neumann DA, Burek CL, Baughman KL, Rose NR, Herskowitz A (1990) Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol 16: 839–846

    Article  CAS  PubMed  Google Scholar 

  20. Caforio AL, Mahon NJ, Tona F, McKenna WJ (2002) Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: Pathogenetic and clinical significance. Eur J Heart Fail 4: 411–417

    Article  PubMed  Google Scholar 

  21. Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J, Ishida M, Hiai H, Matsumori A, Minato N et al (2003) Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 9: 1477–1483

    Article  CAS  PubMed  Google Scholar 

  22. Göser S, Andrassy M, Buss SJ, Leuschner F, Volz CH, Öttl R, Zittrich S, Blaudeck N, Hardt SE, Pfitzer G et al (2006) Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 114: 1693–1702

    Article  PubMed  Google Scholar 

  23. Li Y, Heuser JS, Cunningham LC, Kosanke SD, Cunningham MW (2006) Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol 177: 8234–8240

    CAS  PubMed  Google Scholar 

  24. Magnusson Y, Wallukat G, Waagstein F, Hjalmarson Å, Hoebeke J (1994) Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta1-adrenoceptor with positive chronotropic effect. Circulation 89: 2760–2767

    CAS  PubMed  Google Scholar 

  25. Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F (1999) Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 99: 649–654

    CAS  PubMed  Google Scholar 

  26. Christ T, Schindelhauer S, Wettwer E, Wallukat G, Ravens U (2006) Interaction between autoantibodies against the beta1-adrenoceptor and isoprenaline in enhancing L-type Ca2+ current in rat ventricular myocytes. J Mol Cell Cardiol 41: 716–723

    Article  CAS  PubMed  Google Scholar 

  27. Fu LXM, Magnusson Y, Bergh CH, Waagstein F, Hjalmarson Å, Hoebeke J (1993) Localization of a functional autoimmune epitope on the second extracellular loop of the human muscarinic acetylcholine receptor 2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 91: 1964–1968

    Article  CAS  PubMed  Google Scholar 

  28. Limas CJ (1996) Autoimmunity in dilated cardiomyopathy and the major histocompatibility complex. Int J Cardiol 54: 113–116

    Article  CAS  PubMed  Google Scholar 

  29. Limas CJ, Iakovis P, Anyfantakis A, Kroupis C, Cokkinos DV (2004) Familial clustering of autoimmune diseases in patients with dilated cardiomyopathy. Am J Cardiol 93: 1189–1191

    Article  PubMed  Google Scholar 

  30. Hoebeke J (1996) Structural basis of autoimmunity against G protein-coupled membrane receptors. Int J Cardiol 54: 103–111

    Article  CAS  PubMed  Google Scholar 

  31. Mobini R, Maschke H, Waagstein F (2004) New insights into the pathogenesis of dilated cardiomyopathy: Possible underlying mechanisms and therapy. Autoimmun Rev 3: 277–284

    Article  PubMed  Google Scholar 

  32. Elies R, Ferrari I, Wallukat G, Lebesgue D, Chiale P, Elizari M, Rosenbaum M, Hoebeke J, Levin MJ (1996) Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas’ disease. J Immunol 157: 4203–4211

    CAS  PubMed  Google Scholar 

  33. Ferrari I, Levin M, Wallukat G, Elies R, Lebesgue D, Chiale P, Elizari M, Rosenbaum M, Hoebeke J (1995) Molecular mimicry between the immunodominant ribosomal protein PO of Trypanosoma cruzi and a functional epitope on the human beta1-adrenergic receptor. J Exp Med 182: 59–65

    Article  CAS  PubMed  Google Scholar 

  34. Wallukat G, Wollenberger A, Morwinski R, Pitschner HF (1995) Anti-beta1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: Mapping of epitopes in the first and second extracellular loops. J Mol Cell Cardiol 27: 397–406

    Article  CAS  PubMed  Google Scholar 

  35. Magnusson Y, Hjalmarson Å, Hoebeke J (1996) Beta1-adrenoceptor autoimmunity in cardiomyopathy. Int J Cardiol 54: 137–141

    Article  CAS  PubMed  Google Scholar 

  36. Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM (1999) Chlamydia infections and heart disease linked through antigenic mimicry. Science 283: 1335–1339

    Article  CAS  PubMed  Google Scholar 

  37. Rose NR (2001) Infection, mimics, and autoimmune disease. J Clin Invest 107: 943–944

    Article  CAS  PubMed  Google Scholar 

  38. Eriksson U, Ricci R, Hunziker L, Kurrer MO, Oudit GY, Watts TH, Sonderegger I, Bachmaier K, Kopf M, Penninger JM (2003) Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 9: 1484–1490

    Article  CAS  PubMed  Google Scholar 

  39. Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW (1957) Chronic thyreoiditis and autoimmunization. J Am Med Assoc 164: 1439–1447

    CAS  PubMed  Google Scholar 

  40. Rose NR, Bona C (1993) Defining criteria for autoimmune diseases (Witebsky’s postulates revisited). Immunol Today 14: 426–430

    Article  CAS  PubMed  Google Scholar 

  41. Portig I, Pankuweit S, Maisch B (1997) Antibodies against stress proteins in sera of patients with dilated cardiomyopathy. J Mol Cell Cardiol 29: 2245–2251

    Article  CAS  PubMed  Google Scholar 

  42. Okazaki T, Honjo T (2005) Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy. Trends Mol Med 11: 322–326

    Article  CAS  PubMed  Google Scholar 

  43. Liu B, Dai J, Zheng H, Stoilova D, Sun S, Li Z (2003) Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases. Proc Natl Acad Sci USA 100: 15824–15829

    Article  CAS  PubMed  Google Scholar 

  44. Reichlin M (1998) Cellular dysfunction induced by penetration of autoantibodies into living cells: Cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P protein. J Autoimmun 11: 557–561

    Article  CAS  PubMed  Google Scholar 

  45. Schulze K, Becker BF, Schauer R, Schultheiss HP (1990) Antibodies to ADP-ATP carrier — an autoantigen in myocarditis and dilated cardiomyopathy-impair cardiac function. Circulation 81: 959–969

    CAS  PubMed  Google Scholar 

  46. Khoynezhad A (2007) Promising aspects and caveats of studies on anti-apoptotic therapies in patients with heart failure. Eur J Heart Fail 9: 120–123

    Article  PubMed  Google Scholar 

  47. Nishimura H, Okazaki T, Tanaka Y, Natakani K, Hara M, Matsumori A et al (2001) Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291: 319–322

    Article  CAS  PubMed  Google Scholar 

  48. Caforio AL, Grazzini M, Mann JM, Keeling PJ, Botazzo GF, McKenna WJ, Schiaffino S (1992) Identification of a-and b-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85: 1734–1742

    CAS  PubMed  Google Scholar 

  49. Lauer B, Schannwell M, Kühl U, Strauer BE, Schultheiss HP (2001) Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol 35: 11–18

    Article  Google Scholar 

  50. Neu N, Ploier B, Öfner C (1990) Cardiac myosin-induced myocarditis: Heart autoantibodies are not involved in the induction of the disease. J Immunol 145: 4094–4100

    CAS  PubMed  Google Scholar 

  51. Lohse MJ, Engelhardt S, Eschenhagen T (2003) What is the role of beta-adrenergic signaling in heart failure? Circ Res 93: 896–906

    Article  CAS  PubMed  Google Scholar 

  52. Matsui S, Fu M, Shimizu M, Fukuoka T, Teraoka K, Takekoshi N, Murakami E, Hjalmarson A (1995) Dilated cardiomyopathy defines serum autoantibodies against G protein-coupled cardiovascular receptors. Autoimmunity 21: 85–88

    Article  CAS  PubMed  Google Scholar 

  53. Wang WZ, Zhao RR, Wu BW, Jin XH, Zuh L, Hjalmarson A, Fu LXM (1996) Effects of anti-peptide antibodies against human M2 muscarinic receptors on cardiac function of rats in vivo. Blood Press Suppl 3: 25–27

    Google Scholar 

  54. Baba A, Yoshikawa T, Fukuda Y, Sugiyama T, Shimada M, Akaishi M, Tsuchimoto K, Ogawa S, Fu M (2004) Autoantibodies against M2-muscarinic acetylcholine receptors: New upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur Heart J 25: 1108–1115

    Article  CAS  PubMed  Google Scholar 

  55. Iwata M, Yoshikawa T, Baba A, Anzai T, Mitamura H, Ogawa S (2001) Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 37: 418–424

    Article  CAS  PubMed  Google Scholar 

  56. Christ T, Wettwer E, Dobrev D, Adolph E, Knaut M, Wallukat G, Ravens U (2001) Autoantibodies against the beta1-adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol 33: 1515–1525

    Article  CAS  PubMed  Google Scholar 

  57. Iwata M, Yoshikawa T, Baba A, Anzai T, Nakamura I, Wainai Y, Takahashi T, Ogawa S (2001) Autoimmunity against the second extracellular loop of beta1-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo. Circ Res 88: 578–586

    CAS  PubMed  Google Scholar 

  58. Jahns R, Siegmund C, Jahns V, Reiländer H, Maidhof A, Müller-Esterl W, Lohse MJ, Boege F (1996) Probing human beta1-and beta2-adrenoceptors with domain-specific fusion protein antibodies. Eur J Pharmacol 316: 111–121

    Article  CAS  PubMed  Google Scholar 

  59. Jahns R, Boivin V, Krapf T, Wallukat G, Boege F, Lohse MJ (2000) Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies. J Am Coll Cardiol 36: 1280–1287

    Article  CAS  PubMed  Google Scholar 

  60. Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ (2004) Direct evidence for a beta1-adrenergic receptor directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113: 1419–1429

    CAS  PubMed  Google Scholar 

  61. Engelhardt S, Hein L, Wiesmann F, Lohse MJ (1999) Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA 96: 7059–7064

    Article  CAS  PubMed  Google Scholar 

  62. Woodiwiss AJ, Tsotetsi OJ, Sprott S, Lancaster EJ, Mela T, Chung ES, Meyer TE, Norton GR (2001) Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction. Circulation 103: 155–160

    CAS  PubMed  Google Scholar 

  63. Hershko AY, Naparstek Y (2005) Removal of pathogenic autoantibodies by immunoadsorption. Ann NY Acad Sci 1051: 635–646

    Article  CAS  PubMed  Google Scholar 

  64. Jahns R, Boivin V, Siegmund C, Boege F, Lohse MJ, Inselmann G (1999) Activating beta1-adrenoceptor antibodies are not associated with cardiomyopathies secondary to valvular or hypertensive heart disease. J Am Coll Cardiol 34: 1545–1551

    Article  CAS  PubMed  Google Scholar 

  65. Limas CJ, Goldenberg IF, Limas C (1992) Assessment of immune modulation of betaadrenergic pathways in human dilated cardiomyopathy: Influence of methodologic factors. Am Heart J 123: 967–970

    Article  CAS  PubMed  Google Scholar 

  66. Nikolaev VO, Boivin V, Stoerk S, Angermann CE, Ertl G, Lohse MJ, Jahns R (2007) A novel fluorescent method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure. J Am Coll Cardiol 50: 423–31

    Article  CAS  PubMed  Google Scholar 

  67. Chiale PA, Ferrari I, Mahler E, Vallazza MA, Elizari MV, Rosenbaum MB, Levin MJ (2001) Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 103: 1765–1771

    CAS  PubMed  Google Scholar 

  68. Störk S, Boivin V, Horf R, Hein L, Lohse MJ, Angermann CE, Jahns R (2006) Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Am Heart J 152: 697–704

    Article  PubMed  Google Scholar 

  69. Wallukat G, Müller J, Hetzer R (2002) Specific removal of beta1-adrenergic antibodies directed against cardiac proteins from patients with idiopathic dilated cardiomyopathy. N Engl J Med 347: 1806

    Article  PubMed  Google Scholar 

  70. Anderton SM (2001) Peptide-based immunotherapy of autoimmunity: A path of puzzles, paradoxes, and possibilities. Immunology 104: 367–376

    Article  CAS  PubMed  Google Scholar 

  71. Mobini R, Staudt A, Felix SB, Baumann G, Wallukat G, Deinum J, Hjalmarson Å, Fu M (2003) Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmunity 20: 345–350

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Medizinische Klinik und Poliklinik I, Cardiology, University Hospital of Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg

    Roland Jahns & Georg Ertl

  2. Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Str. 9, 97078, Würzburg, Germany

    Roland Jahns, Valérie Boivin & Martin J. Lohse

Authors
  1. Roland Jahns
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Valérie Boivin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Georg Ertl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Martin J. Lohse
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Cardiology and Pneumology, Charité—Universitätsmedizin Berlin Campus Benjamin Franklin, Hinderburgdamm 30, 12200, Berlin, Germany

    Heinz-Peter Schultheiss  & Michel Noutsias  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Basel

About this chapter

Cite this chapter

Jahns, R., Boivin, V., Ertl, G., Lohse, M.J. (2010). Pathogenic relevance of autoantibodies in dilated cardiomyopathy. In: Schultheiss, HP., Noutsias, M. (eds) Inflammatory Cardiomyopathy (DCMi). Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-8352-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-7643-8352-7_7

  • Publisher Name: Birkhäuser Basel

  • Print ISBN: 978-3-7643-8351-0

  • Online ISBN: 978-3-7643-8352-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation